Markets:

Overview

News

Currencies

International

Treasuries

LifeStance Health Group, Inc. - Common Stock (NQ:LFST)

6.910 -0.020 (-0.29%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about LifeStance Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

October 09, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Winners And Losers Of Q2: LifeStance Health Group (NASDAQ:LFST) Vs The Rest Of The Outpatient & Specialty Care Stocks

September 15, 2025

Looking back on outpatient & specialty care stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including LifeStance Health Group (NASDAQ:LFST) and its peers.

Via StockStory

Topics Artificial Intelligence

Why LifeStance Health Group (LFST) Shares Are Getting Obliterated Today

September 10, 2025

Shares of behavioral health company LifeStance Health (NASDAQ:LFST) fell 5.6% in the afternoon session after the company detailed operational challenges at a recent investor conference.

Via StockStory

Topics Economy Initial Public Offering

3 Hyped Up Stocks We’re Skeptical Of

September 09, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

LifeStance Health Gr's Earnings Outlook ↗

August 06, 2025

Via Benzinga

1 Healthcare Stock to Target This Week and 2 We Ignore

September 04, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference

August 26, 2025

From LifeStance Health, Inc.

Via GlobeNewswire

1 High-Flying Stock Worth Your Attention and 2 We Find Risky

August 21, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

Via StockStory

3 Cash-Producing Stocks with Open Questions

August 19, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Earnings Economy

LFST Q2 Deep Dive: Productivity Initiatives and Technology Investments Drive Margin Expansion

August 12, 2025

Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.6% year on year to $345.3 million. On the other hand, next quarter’s...

Via StockStory

Why LifeStance Health Group (LFST) Stock Is Up Today

August 08, 2025

Shares of behavioral health company LifeStance Health (NASDAQ:LFST) jumped 11% in the afternoon session after the company reported mixed second-quarter 2025 results, delivering an earnings beat and a...

Via StockStory

Topics Earnings Initial Public Offering Lawsuit

LifeStance Health Group’s (NASDAQ:LFST) Q2 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations

August 07, 2025

Via StockStory

LifeStance Health Group Inc (NASDAQ:LFST) Reports Q2 2025 Revenue Growth and Narrowed Losses ↗

August 07, 2025

LifeStance Health reports Q2 2025 revenue growth of 11% to $345.3M, narrowed losses, and strong cash flow. Shares remain muted despite improved profitability and raised EBITDA guidance.

Via Chartmill

LifeStance (LFST) Q2 Revenue Jumps 11% ↗

August 07, 2025

Via The Motley Fool

LifeStance Reports Second Quarter 2025 Results

August 07, 2025

From LifeStance Health, Inc.

Via GlobeNewswire

LifeStance Health Group (LFST) Reports Earnings Tomorrow: What To Expect

August 05, 2025

Behavioral health company LifeStance Health (NASDAQ:LFST) will be reporting earnings this Thursday before the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

3 Stocks Under $10 with Warning Signs

August 04, 2025

Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack...

Via StockStory

Topics Supply Chain

3 Small-Cap Stocks We Find Risky

August 01, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 Facing Headwinds

July 31, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

July 17, 2025

From LifeStance Health, Inc.

Via GlobeNewswire

Why LifeStance Health Group (LFST) Stock Is Trading Lower Today

July 11, 2025

Shares of behavioral health company LifeStance Health (NASDAQ:LFST) fell 3.4% in the afternoon session after the stock hit a new 52-week low of $4.60. The drop reflects ongoing investor concerns and...

Via StockStory

Topics Artificial Intelligence Economy Government

1 Healthcare Stock with Competitive Advantages and 2 to Be Wary Of

July 10, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

1 Oversold Stock Ready to Bounce Back and 2 to Keep Off Your Radar

July 07, 2025

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

3 Cash-Producing Stocks with Open Questions

June 27, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

3 of Wall Street’s Favorite Stocks Facing Headwinds

June 20, 2025

Via StockStory

Topics Economy

3 Unprofitable Stocks in Hot Water

June 11, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

LFST Q1 Earnings Call: Outpatient Behavioral Health Sees Stable Growth, Margin Improvement, and Shifts in Clinician Incentives

June 10, 2025

Behavioral health company LifeStance Health (NASDAQ:LFST) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.8% year on year to $333 million. Its non-GAAP profit of $0.05 per share...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.